Researchers have used machine learning and two experimental designs to optimize a common critical quality attribute of biological therapies.

Eliza Yeung, PhD, associate director of process characterization at contract manufacturer Cytovance Biologics, and another researcher relied on statistical software to create two experimental designs to analyze glycosylation, a critical quality attribute of therapeutic glycoproteins. The study was published in the BioProcessing Journal last October.

Source: https://www.genengnews.com/news/machine-learning-to-optimize-product-quality-measurement/


0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

Facebook
LinkedIn